HLA-B27 heavy chains distinguished by a micropolymorphism exhibit differential flexibility

Arthritis and Rheumatism

Volumn 62, Issue 4, 2010, Pages 978-987

  Fabian, Heinz ^a   Huser, Hans ^b   Loll, Bernhard ^c   Ziegler, Andreas ^b   Naumann, Dieter ^a   Uchanska Ziegler, Barbara ^b  

^a ROBERT KOCH INSTITUTE   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c MAX PLANCK INSTITUTE FOR MEDICAL RESEARCH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN; HLA ANTIGEN; HLA B ANTIGEN; HLA B27 ANTIGEN; ISOTOPE; PEPTIDE;

ARTICLE; CELL SURFACE; COMPLEX FORMATION; CONFORMATION; DISEASE ASSOCIATION; EFFECTOR CELL; GENETIC POLYMORPHISM; IN VITRO STUDY; INFRARED SPECTROSCOPY; NONHUMAN; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SPONDYLOARTHROPATHY; TEMPERATURE; VIRUS; X RAY CRYSTALLOGRAPHY;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ESCHERICHIA COLI; HLA-B27 ANTIGEN; HUMANS; INCLUSION BODIES; MODELS, MOLECULAR; PEPTIDE FRAGMENTS; POLYMORPHISM, GENETIC; PROTEIN CONFORMATION; SPECTROPHOTOMETRY, INFRARED; SPONDYLARTHRITIS;

EID: 77950531623     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.27316     Document Type: Article

References (48)

1. Lopez de Castro JA. HLA-B27 and the pathogenesis of spondyloarthropathies. Immunol Lett 2007;108:27-33.
2. Taurog JD. The mystery of HLA-B27: if it isn't one thing, it's another [editorial]. Arthritis Rheum 2007;56:2478-2481
3. Khan MA, Mathieu A, Sorrentino R, Akkoc N. The pathogenetic role of HLA-B27 and its subtypes. Autoimmun Rev 2007;6:183-189
4. D'Amato M, Fiorillo MT, Carcassi C, Mathieu A, Zuccarelli PP, Bitti R, et al. Relevance of residue 116 of HLA-B27 in determining susceptibility to ankylosing spondylitis. Eur J Immunol 1995; 25:3199-3201
5. Madden DR. The three-dimensional structure of peptide-MHC complexes. Annu Rev Immunol 1995;13:587-622.
6. Ziegler A, Loll B, Misselwitz R, Uchanska-Ziegler B. Implications of structural and thermodynamic studies of HLA-B27 subtypes exhibiting differential association with ankylosing spondylitis. Adv Exp Med Biol 2009;649:177-195
7. Fiorillo MT, Cauli A, Carcassi C, Bitti PP, Vacca A, Passiu G, et al. Two distinctive HLA haplotypes harbor the B27 alleles negatively or positively associated with ankylosing spondylitis in Sardinia: implications for disease pathogenesis. Arthritis Rheum 2003; 48:1385-1389
8. + T-cell autoreactivity to an HLA-B27-restricted self-epitope correlates with ankylosing spondylitis. J Clin Invest 2000;106: 47-53.
9. Ramos M, Paradela A, Vazquez M, Marina A, Vazquez J, Lopez de Castro JA. Differential association of HLA-B*2705 and B*2709 to ankylosing spondylitis correlates with limited peptide subsets but not with altered cell surface stability. J Biol Chem 2002;277:28749-28756
10. Lopez de Castro JA, Alvarez I, Marcilla M, Paradela M, Ramos M, Sesma L, et al. HLA-B27: a registry of constitutive peptide ligands. Tissue Antigens 2004;63:424-445
11. Hulsmeyer M, Fiorillo MT, Bettosini F, Sorrentino R, Saenger W, Ziegler A, et al. Dual, HLA-B27 subtype-dependent conformation of a self-peptide. J Exp Med 2004;199:271-281
12. Fiorillo MT, Ruckert C, Hulsmeyer M, Sorrentino R, Saenger W, Ziegler A, et al. Allele-dependent similarity between viral and self-peptide presentation by HLA-B27 subtypes. J Biol Chem 2005;280:2962-2971
13. Ruckert C, Fiorillo MT, Loll B, Moretti R, Biesiadka J, Saenger W, et al. Conformational dimorphism of self-peptides and molecular mimicry in a disease-associated HLA-B27 subtype. J Biol Chem 2006;281:2306-2316
14. Beltrami A, Rossmann M, Fiorillo MT, Paladini F, Sorrentino R, Saenger W, et al. Citrullination-dependent differential presentation of a self-peptide by HLA-B27 subtypes. J Biol Chem 2008; 283:27189-27199
15. Hulsmeyer M, Welfle K, Pohlmann T, Misselwitz R, Alexiev U, Welfle W, et al. Thermodynamic and structural equivalence of two HLA-B27 subtypes complexed with a self-peptide. J Mol Biol 2005;346:1367-1379
16. ColbertRA.HLA-B27misfolding: a solution to the spondyloarthropathy conundrum? Mol Med Today 2000;6:224-230
17. 2-microglobulin-free heavy chain homodimer structure. J Immunol 1999;162:5045-5048
18. 2m: an animal model of HLA-B27-associated human disorders. Cell 1990;63:1099-1112
19. Ramos M, Alvarez I, Sesma L, Logean A, Rognan D, Lopez de Castro JA. Molecular mimicry of an HLA-B27-derived ligand of arthritis-linked subtypes with chlamydial proteins. J Biol Chem 2002;277:37573-37581
20. Kumar P, Vahedi-Faridi A, Saenger W, Merino E, Lopez de Castro JA, Uchanska-Ziegler B, et al. Structural basis for T cell alloreactivity among three HLA-B14 and HLA-B27 antigens. J Biol Chem 2009;284:29784-29797
21. Pohlmann T, Bockmann RA, Grubmuller H, Uchanska-Ziegler B, Ziegler A, Alexiev U. Differential peptide dynamics is linked to MHC polymorphism. J Biol Chem 2004;279:28197-28201
22. Winkler K, Winter A, Ruckert C, Uchanska-Ziegler B, Alexiev U. Natural MHC class I polymorphism controls the pathway of peptide dissociation from HLA-B27 complexes. Biophys J 2007; 93:2743-2755
23. Narzi D, Winkler K, Saidowsky J, Misselwitz R, Ziegler A, Bockmann RA, et al. Molecular determinants of major histocompatibility complex class I complex stability: shaping antigenic features through short range and long range electrostatic interactions. J Biol Chem 2008;283:23093-23103
24. Fabian H, Huser H, Narzi D, Misselwitz R, Loll B, Ziegler A, et al. HLA-B27 subtypes differentially associated with disease exhibit conformational differences in solution. J Mol Biol 2008;376: 798-810.
25. Taurog JD. Animal models of spondyloarthritis. Adv Exp Med Biol 2009;649:245-254
26. Fabian H, Mantele W. Infrared spectroscopy of proteins. In: Chalmers JM, Griffiths PR, editors. Handbook of vibrational spectroscopy. Chichester (UK): John Wiley & Sons; 2002. p. 3399-3425
27. Barth A. Infrared spectroscopy of proteins. Biochim Biophys Acta 2007;1767:1073-1101
28. Englander SW, Kallenbach NR. Hydrogen exchange and structural dynamics of proteins and nucleic acids [review]. Q Rev Biophys 1983;4:521-655.
29. Hulsmeyer M, Hillig RC, Volz A, Ruhl M, Schroder W, Saenger W, et al. HLA-B27 subtypes differentially associated with disease exhibit subtle structural alterations. J Biol Chem 2002;277: 47844-47853
30. Garboczy DN, Hung DT, Wiley DC. HLA-A2-peptide complexes: refolding and crystallization of molecules expressed in Escherichia coli and complexed with single antigenic peptides. Proc Natl Acad Sci U S A 1992;89:3429-3433
31. Frauenfelder H, Chen G, Berendzen J, Fenimore PW, Jansson H, McMahon BH, et al. A unified model of protein dynamics. Proc Natl Acad Sci U S A 2009;106:5129-5134
32. Angel TE, Gupta S, Jastrzebska B, Palczewski K, Chance MR. Structural waters define a functional channel mediating activation of the GPCR, rhodopsin. Proc Natl Acad Sci U S A 2009;106: 14367-14372
33. Ogata K, Wodak SJ. Conserved water molecules in MHC class-I molecules and their putative structural and functional roles. Protein Eng 2002;15:697-705.
34. Macdonald WA, Purcell AW, Mifsud NA, Ely LK, Williams DS, Chang L, et al. A naturally selected dimorphism within the HLA-B44 supertype alters class I structure, peptide repertoire, and T cell recognition. J Exp Med 2003;198:679-691
35. Hillig RC, Hulsmeyer M, Welfle K, Misselwitz R, Welfle W, Saenger W, et al. Thermodynamic and structural analysis of peptide- and allele-dependent properties of two HLA-B27 subtypes exhibiting differential disease association. J Biol Chem 2004;279:652-663
36. Ziegler A, Muller CA, Bockmann RA, Uchanska-Ziegler B. Low-affinity peptides and T-cell selection. Trends Immunol 2009; 30:53-61.
37. Bjorkman PJ, Parham P. Structure, function, and diversity of class I major histocompatibility complex molecules. Annu Rev Biochem 1990;59:253-288
38. Stewart-Jones GB, di Gleria K, Kollnberger S, McMichael AJ, Jones EY, Bowness P. Crystal structures and KIR3DL1 recognition of three immunodominant viral peptides complexed to HLA-B*2705. Eur J Immunol 2005;35:341-351
39. Henzler-Wildman K, Kern D. Dynamic personalities of proteins. Nature 2007;450:964-972
40. Rudolph MG, Stanfield RL, Wilson IA. How TCRs bind MHCs, peptides, and coreceptors. Annu Rev Immunol 2006;24:419-466
41. Boyington JC, Sun PD. A structural perspective on MHC class I recognition by killer cell immunoglobulin-like receptors. Mol Immunol 2002;38:1007-1021
42. 2-microglobulin-transgenic rats is not prevented by lack of CD8. Arthritis Rheum 2009;60:1977-1984.
43. Wang JH, Smolyar A, Tan K, Liu JH, Kim M, Sun ZY, et al. Structure of a heterophilic adhesion complex between the human CD2 and CD58 (LFA-3) counterreceptors. Cell 1999;97:791-803.
44. Kollnberger S, Chan A, Sun MY, Chen LY, Wright C, di Gleria K, et al. Interaction of HLA-B27 homodimers with KIR3DL1 and KIR3DL2, unlike HLA-B27 heterotrimers, is independent of the sequence of bound peptide. Eur J Immunol 2007;37:1313-1322
45. Diaz-Pena R, Blanco-Gelaz MA, Lopez-Larrea C. KIR genes and their role in spondyloarthropathies. Adv Exp Med Biol 2009;649: 286-299
46. Galocha B, Lopez de Castro JA. Folding of HLA-B27 subtypes is determined by the global effect of polymorphic residues and shows incomplete correspondence to ankylosing spondylitis. Arthritis Rheum 2008;58:401-412
47. Blanco-Gelaz MA, Suarez-Alvarez B, Diaz-Pena R, Lopez-Larrea C. HLA-B27 polymorphism at position 116 critically influences the association with TAP/tapasin, intracellular trafficking and conformational homodimers formation. Mol Immunol 2009;46: 1304-1311
48. Dong G, Wearsch PA, Peaper DR, Cresswell P, Reinisch KM. Insights into MHC class I peptide loading from the structure of the tapasin-ERp57 thiol oxioreductase heterodimer. Immunity 2009; 30:21-32.